Tech Company Financing Transactions

Pluton Biosciences Funding Round

Pluton Biosciences secured a $16.5 million Series A funding round on 5/24/2023. Investors included Illumina Ventures, RA Capital and Fall Line Capital.

Transaction Overview

Company Name
Announced On
5/24/2023
Transaction Type
Venture Equity
Amount
$16,500,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to accelerate the development of its flagship product, the Microbial Cover Crop, through field trials and commercial partnerships.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11754 Westline Industrial Drive
St. Louis, MT 63146
USA
Email Address
Overview
The Pluton Biosciences team brings together scientists, entrepreneurs, technologists, and an advisory board of accomplished scientists with a shared passion for protecting our climate, our planet and the people who call it home. Our executive team includes start-up leaders with successful exits, PhD-level scientists in the fields of genetics, microbiology, and biochemistry; a CEO with extensive AgTech start-up experience in finance, business development, fund raising and operations, a CSO skilled at computational biology and building world-class microbial discovery pipelines; and a COO with deep expertise in molecular biology, laboratory automation, and data management as well as an Executive Chair with deep industry leadership experience in large and small companies.
Profile
Pluton Biosciences LinkedIn Company Profile
Social Media
Pluton Biosciences Company Twitter Account
Company News
Pluton Biosciences News
Facebook
Pluton Biosciences on Facebook
YouTube
Pluton Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Elizabeth Gallegos
  Elizabeth Gallegos LinkedIn Profile  Elizabeth Gallegos Twitter Account  Elizabeth Gallegos News  Elizabeth Gallegos on Facebook
Chief Operating Officer
Kirk Narzinski
  Kirk Narzinski LinkedIn Profile  Kirk Narzinski Twitter Account  Kirk Narzinski News  Kirk Narzinski on Facebook
Chief Scientific Officer
Barry Goldman
  Barry Goldman LinkedIn Profile  Barry Goldman Twitter Account  Barry Goldman News  Barry Goldman on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/24/2023: SkorLife venture capital transaction
Next: 5/24/2023: WireMock venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary